Asonor Marketing Corp. Announces U.S. Launch Of ASONOR® Scandinavian Stop Snoring Nasal Remedy

Dec. 19, 2007 - PRLog -- Asonor® has been available for a number of years in Europe and has achieved remarkable success for its customers in helping reduce snoring and its effects on persons as well as phenomenal sales results for Tanner Medico A/S.
Scientific research in England, Germany and Holland was the background for the very comprehensive clinical studies, which were carried out at the University State Hospital (Rigshospitalet) of Copenhagen, Denmark.
The Clinical Testing results show that 65% of social snorers are satisfied with Asonor®. These results were outstanding, which affords a high degree of certainty that snoring and the inconvenience caused by snoring will be relieved with the use of Asonor®. Users sleep better and wake up refreshed after a good nights sleep.
3-4 Sprays in each nostril just before bedtime is usually enough to provide relief for snoring. Asonor® is an Over The Counter product that has been found to have no known drug interactions or side-effects. Consumers can find out more about Asonor® by visiting www.asonormarketing.com. Special product launch introductory pricing is now available and a one month’s supply is currently selling for $24.99.
Asonor® Scandinavian Stop Snoring Nasal Remedy is manufactured to the highest GMP (Good Manufacturing Standards) in the EU, and is imported and Distributed in the United States by Asonor Marketing Corporation.

Website: asonormarketing.com